9411 N OAK TRFY, Kansas City, MO
Contact for insurance details
9401 N OAK TRFY, Kansas City, MO
Contact for insurance details
930 CARONDELET DR STE 201, Kansas City, MO
Contact for insurance details
901 E 104TH ST, Kansas City, MO
Contact for insurance details
2301 HOLMES ST, Kansas City, MO
Contact for insurance details
5844 NW BARRY RD, Kansas City, MO
Contact for insurance details
2301 HOLMES ST, Kansas City, MO
Contact for insurance details
5844 NW BARRY RD, Kansas City, MO
Contact for insurance details
2301 HOLMES ST, Kansas City, MO
Contact for insurance details
4000 CAMBRIDGE ST, Kansas City, KS
Contact for insurance details
## GLP-1 Weight Loss Clinics in Kansas City, MO Kansas City is home to 26 GLP-1 weight loss providers, including endocrinologists, obesity medicine specialists, internal medicine physicians, and weight management clinics. The Kansas City metropolitan area has an adult obesity rate of 33.5%, and demand for GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) continues to grow. ## Finding the Right Provider When choosing a GLP-1 provider in Kansas City, look for board-certified physicians with experience in obesity medicine or endocrinology. Qualified providers conduct thorough medical evaluations before prescribing, offer ongoing monitoring during dose titration, and provide nutritional counseling alongside medication. Our directory lists providers with verified NPI credentials, so you can confirm their licensure and specialty before scheduling an appointment. ## Insurance and Cost Missouri Medicaid does not currently cover GLP-1 medications for obesity. Patients without commercial insurance coverage can access manufacturer discount programs, including LillyDirect Zepbound vials at $299 to $449 per month and NovoCare Wegovy at $499 per month. For commercially insured patients, most major carriers in Missouri now cover at least one GLP-1 medication for weight management with prior authorization. Manufacturer savings cards can reduce copays to $0 to $25 per month for eligible patients. Oral Wegovy, the newest formulation approved in December 2025, is available at $149 to $299 per month through select pharmacies, offering a lower-cost alternative to injectable options. ## Telehealth Options Missouri permits telehealth prescribing by state-licensed providers. Missouri Medicaid (MO HealthNet) does not currently cover GLP-1 medications for obesity. Many providers in Kansas City now offer both in-person and telehealth consultations, giving patients flexibility in how they access care. Telehealth can be particularly convenient for monthly follow-up visits during GLP-1 treatment.
Our directory lists 26 GLP-1 providers in Kansas City, MO, including endocrinologists, obesity medicine specialists, and weight management clinics. This count is based on NPI Registry data and is updated regularly.
No. Missouri Medicaid does not currently cover GLP-1 medications for obesity. Coverage is limited to diabetes indications. Cash-pay options include LillyDirect Zepbound vials ($299 to $449 per month) and NovoCare Wegovy ($499 per month).
Yes. Missouri permits telehealth prescribing of GLP-1 medications by state-licensed providers. Many clinics in Kansas City offer both in-person and virtual consultations.
Costs vary by medication and insurance status. With commercial insurance and a manufacturer savings card, copays typically range from $0 to $50 per month. Without insurance, options include oral Wegovy ($149 to $299 per month), LillyDirect Zepbound vials ($299 to $449 per month), and NovoCare Wegovy ($499 per month).
Look for board-certified providers in obesity medicine (ABOM), endocrinology, or internal medicine. Verify their NPI credentials, ask about their experience with GLP-1 prescribing, and confirm they offer ongoing monitoring and nutritional support alongside medication.
Missouri permits telehealth prescribing by state-licensed providers. Missouri Medicaid (MO HealthNet) does not currently cover GLP-1 medications for obesity.
Medical Disclaimer
The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. GLP-1 receptor agonists are prescription medications. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary.